CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 446 enrolled
Drug / intervention
Recovery Management Checkups (RMC)behavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01153594
NCT01153594Phase 3Completed

Early Re-Intervention (ERI) Experiment 2

Chestnut Health Systems·interventional·Posted Jun 30, 2010·Updated Jun 30, 2010

In Brief

A Phase 3 clinical trial evaluating Recovery Management Checkups (RMC) for Substance Use Disorders. Completed, enrolled 446 participants across 1 site.

Detailed Summary

The objective of this study was to evaluate the relative effectiveness of quarterly Recovery Management Checkups (RMC) on long-term outcomes of adult chronic substance users over 4 years.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

Phase 3CompletedFinished
200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 30, 2010
Enrollment StartFeb 1, 2004
Primary CompletionJun 1, 2008
Study CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 4.3 yearsPosted 16.0 years ago

Interventions

Recovery Management Checkups (RMC)behavioral

After interviewers completed the quarterly research interview and determined participants' eligibility and need for early re-intervention, they transferred RMC participants who were eligible and in need to a Linkage Manager. Using motivational interviewing, the Linkage Manager: a) provided feedback to participants regarding their current substance use and related problems, b) discussed implications of managing addiction as a chronic condition, c) discussed treatment barriers and solutions, d) assessed and discussed level of motivation for treatment, e) scheduled treatment appointments, f) accompanied participants to treatment intake and stayed through the process, and g) implemented Engagement and Retention Protocol during the 14 days of treatment